Skip to main content
. 2018 Mar 2;15(5):6368–6376. doi: 10.3892/ol.2018.8156

Table V.

Overall survival and quality of life analysis.

Variable Total PPPD SPD P-value
OS 45.6 (4–144)c 55.1 (4–142)c 40.1 (4–144)c 0.126a
OS of positive lymph nodes (EORTC)-QLQ-C30 25.2 (4–56)c 27.4 (4–56)c 24.0 (4–54)c 0.592a
Physical functioning
  6 months 49.8 (18.2) 53.6 (16.2) 47.7 (19.1) 0.189b
  24 months 49.2 (15.4) 52.3 (15.5) 47.5 (15.3) 0.210b
Role functioning
  6 months 50.9 (21.8) 50.6 (23.8) 51.1 (20.9) 0.934b
  24 months 41.8 (21.8) 44.8 (24.8) 40.2 (20.0) 0.389b
Emotional functioning
  6 months 44.6 (14.6) 40.9 (16.0) 45.1 (14.0) 0.742b
  24 months 42.9 (17.5) 43.3 (18.6) 42.7 (17.1) 0.893b
Cognitive functioning
  6 months 55.5 (22.3) 57.0 (23.6) 54.7 (21.8) 0.673b
  24 months 46.9 (20.8) 48.7 (19.9) 46.0 (21.4) 0.600b
Social functioning
  6 months 39.1 (21.3) 41.6 (23.2) 37.6 (20.3) 0.450b
  24 months 47.4 (21.2) 44.2 (23.5) 49.2 (19.8) 0.336b
Overall quality of life
  6 months 46.8 (16.1) 43.9 (16.7) 48.5 (15.7) 0.244b
  24 months 47.1 (20.0) 49.3 (21.4) 45.8 (19.3) 0.477b
Appetite loss
  6 months 41.2 (31.4) 26.9 (24.9) 49.3 (32.0) 0.003b,d
  24 months 45.3 (28.6) 47.3 (31.5) 44.2 (27.2) 0.649b
Nausea and vomiting
  6 months 41.0 (24.1) 40.3 (25.0) 41.3 (23.9) 0.868b
  24 months 38.1 (22.1) 42.3 (24.1) 35.8 (20.7) 0.237b
Diarrhea
  6 months 29.1 (26.7) 28.2 (26.1) 29.7 (27.4) 0.820b
  24 months 22.6 (21.5) 21.7 (20.9) 23.1 (22.0) 0.794b
a

Log-rank test

b

Student's t-test.

c

Values are presented as the median (range), as opposed to the mean (standard deviation) presentation used for all other data.

d

P<0.05. PPPD, pylorus-preserving pancreaticoduodenectomy; SPD, standard pancreaticoduodenectomy; OS, overall survival; EORTC, European Organization for Research and Treatment of Cancer.